| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 504.75M | 520.81M | 486.80M | 468.24M | 483.07M |
| Gross Profit | 110.90M | 121.94M | 105.12M | 77.08M | 53.52M |
| EBITDA | 68.73M | 85.46M | 82.21M | 60.89M | 76.99M |
| Net Income | 17.79M | 33.60M | 27.75M | 596.00K | 583.00K |
Balance Sheet | |||||
| Total Assets | 263.23M | 267.25M | 267.67M | 251.81M | 275.68M |
| Cash, Cash Equivalents and Short-Term Investments | 55.38M | 50.60M | 76.36M | 55.22M | 45.07M |
| Total Debt | 59.29M | 58.84M | 71.35M | 81.40M | 104.91M |
| Total Liabilities | 105.26M | 104.69M | 118.99M | 120.87M | 145.01M |
| Stockholders Equity | 154.13M | 158.35M | 144.74M | 126.99M | 126.39M |
Cash Flow | |||||
| Free Cash Flow | 69.11M | 54.71M | 82.77M | 72.71M | 92.17M |
| Operating Cash Flow | 74.52M | 59.00M | 89.10M | 76.43M | 100.41M |
| Investing Cash Flow | -3.70M | -1.91M | -6.97M | -4.07M | -8.22M |
| Financing Cash Flow | -66.04M | -82.12M | -61.30M | -62.23M | -85.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$236.00M | 15.14 | 11.22% | ― | 15.66% | -1.25% | |
65 Neutral | HK$216.00M | 3.98 | 11.11% | 12.66% | 0.15% | -33.33% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
48 Neutral | HK$290.13M | 26.24 | 4.24% | 1.30% | -37.35% | -59.07% | |
45 Neutral | HK$950.07M | 18.53 | 0.23% | 3.51% | 0.55% | -88.72% | |
42 Neutral | HK$479.67M | -61.50 | -16.93% | ― | 0.90% | 94.78% | |
40 Underperform | HK$66.95M | 458.76 | -65.18% | ― | 47.97% | 99.73% |